Izildinha Maestá - Gynecology

Author Information

Izildinha Maestá is affiliated with the Botucatu Trophoblastic Disease Center at the Botucatu Medical School Hospital, Department of Gynecology and Obstetrics, UNESP-Sao Paulo State University, Botucatu, SP, Brazil. She is also involved with the Postgraduate Program in Tocogynecology at the same institution.

Research Contributions

Izildinha Maestá has made substantial contributions in the field of gynecology, specifically focusing on gestational trophoblastic diseases. Her research spans various aspects of this condition, from the risks associated with complete hydatidiform moles to the effectiveness of different chemotherapy protocols and treatment methods. Her work has been published in several high-impact journals, making a significant impact on the understanding and management of trophoblastic diseases.

Aliases

Izildinha Maestá is also known by other names including I Maestá and Izildinha Maesta.

Publication and Citation Metrics

Metric	Value
Total Citations	871
H-Index	17
Total Papers	62

Publications:

Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol

DOI: 10.1136/bmjopen-2021-059484

Year: 2022

Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism.

DOI: 10.1016/j.ygyno.2022.01.037

Year: 2022

Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia

DOI: 10.1007/s43032-021-00634-y

Year: 2021

Distinct microRNA profiles for complete hydatidiform moles at risk for malignant progression.

DOI: 10.1016/j.ajog.2020.09.048

Year: 2020

Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America

DOI: 10.1136/ijgc-2020-001237

Year: 2020

Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.

DOI: 10.1016/j.ygyno.2020.02.001

Year: 2020

Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study.

DOI: 10.1016/j.ygyno.2020.04.704

Year: 2020

Epigenetics tells the mole story: DNA methylation identifies complete moles destined to develop into gestational trophoblastic neoplasia

DOI: 10.1016/J.YGYNO.2019.04.089

Year: 2019

Gestational Trophoblastic Disease in Brazil.

DOI: 10.1055/s-0039-1688566

Year: 2019

Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy.

DOI: 10.1097/AOG.0000000000002522

Year: 2018

What Role Do Inherited Clotting Disorders Play?

How Do Pelvic Floor Stimulators Work?

What are the latest advancements in gynecological medications?

What Types of Studies are Included?

What to Expect During a Gynecological Examination?

Why is Regular Gynecological Checkup Important?

How Can Post Test Probability Affect Clinical Decisions?

How is Fimbriectomy Different from Other Tubal Ligation Methods?

What Are the Benefits of Neuromodulation?

How Effective Are Hemostatic Agents?

Partnered Content Networks

Relevant Topics